Source link : https://newshealth.biz/health-news/twice-yearly-biologic-effective-against-nasal-polyps/
(MedPage Today) — SAN DIEGO — Novel ultra-long-acting biologic depemokimab reduced nasal polyps in chronic rhinosinusitis, two parallel phase III trials showed. Twice-yearly injections cut total nasal polyps score by a mean of 0.7 more than… Source link : https://www.medpagetoday.com/meetingcoverage/aaaai/114450 Author : Publish date : 2025-03-02 22:31:57 Copyright for syndicated content belongs to […]
Author : News Health
Publish date : 2025-03-02 22:31:57
Copyright for syndicated content belongs to the linked Source.
in Health